Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Shire News

Doubts Over Shire's Credit Profile If Bought By Takeda - Moody's
26 Apr 2018

Doubts Over Shire's Credit Profile If Bought By Takeda - Moody's

LONDON (Alliance News) - Moody's Investors Service late Wednesday expressed uncertainty regarding biotechnology company Shire PLC's credit profile fol...

LONDON MARKET EARLY CALL: Shell, Barclays Earnings Due; ECB In Focus
26 Apr 2018

LONDON MARKET EARLY CALL: Shell, Barclays Earnings Due; ECB In Focus

LONDON (Alliance News) - Stocks in London are set to open marginally higher on Thursday, supported by some gains in the US overnight, with focus for t...

UPDATE 1-Roche lifts 2018 outlook as Ocrevus shines, Tecentriq stumbles
26 Apr 2018

UPDATE 1-Roche lifts 2018 outlook as Ocrevus shines, Tecentriq stumbles

ZURICH, April 26 (Reuters) - Roche raised its 2018 sales outlook on Thursday after getting a lift in the first three months of the year from newer dru...

European Markets Drop With Interest Rate Hike Concerns
25 Apr 2018

European Markets Drop With Interest Rate Hike Concerns

BRUSSELS/FRANKFURT/PARIS (Alliance News) - The European markets ended Wednesday's session firmly in negative territory. Investor sentiment took a hit ...

Reuters Business News Schedule at 1500 GMT/11 AM ET
25 Apr 2018

Reuters Business News Schedule at 1500 GMT/11 AM ET

Editor: Steve Orlofsky +1 646 223 6200 Global Picture Desk: +65 6870 3775 Global Graphics Desk: + 65 6870 3595 (All times GMT / ET) Receive this sched...

Reuters Business News Schedule at 1230 GMT/8:30 AM ET
25 Apr 2018

Reuters Business News Schedule at 1230 GMT/8:30 AM ET

Editor: Louise Heavens, +44 207 542 1897 Global Picture Desk: +65 6870 3775 Global Graphics Desk: + 65 6870 3595 (All times GMT / ET) Receive this sch...

GSK rules out entering Shire takeover battle
25 Apr 2018

GSK rules out entering Shire takeover battle

LONDON, April 25 (Reuters) - GlaxoSmithKline's chief executive said on Wednesday she had no interest in acquiring Shire, the London-listed rare diseas...

ANALYSIS-Shire bid marks Takeda's latest - and biggest - push for global status
25 Apr 2018

ANALYSIS-Shire bid marks Takeda's latest - and biggest - push for global status

* CEO Weber continuing predecessor's international push * Japan already accounts for only 30 percent of Takeda's drug sales * Takeda is trying to rebu...